original articlesgastrointestinal tumorsA randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first-line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial
gastrointestinal tumors
Under an Elsevier user license
open archive
Key words
metastatic colorectal cancer
maintenance treatment
bevacizumab
erlotinib
capecitabine
metronomic chemotherapy
Cited by (0)
Copyright © 2015 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.